creos™ syntoprotect mesh
Porosity of a mesh, adaptability of a membrane
Reinforced PTFE mesh, available in 15 shapes for various defects in vertical and horizontal bone augmentation.
A hybrid approach to ridge augmentation
creos™ syntoprotect mesh takes a hybrid approach to ridge augmentation and is offered in various configurations, including shapes with fixation points, trimmable versatile designs for different defects, and interproximal shapes.
Note: Only use creos syntoprotect mesh when primary closure can be achieved and maintained throughout the duration of the healing period.
“creos™ syntoprotect mesh allows the vascularization you get from a mesh, but with the softness of a membrane that remains kind to soft tissues. With the mesh, and the bone quality I see at seven months, I can shorten time to implants by about two months.”
REVASCULARIZATION INFILTRATION
Circular macropores for direct contact between bone graft and periosteum, allowing naturally occurring revascularization and infiltration of cells into the bone graft.
SPACE MAINTENANCE
Titanium frame maintains space essential for horizontal and vertical ridge augmentation.
EASIER TRIMMING AND ADAPTATION
Designed to work like traditional titanium mesh, but with the added benefits of easier trimming and easier adaptation. Easily conforms to tissue contours.
Clinical efficacy and practice efficiency
Questions about creos syntoprotect mesh?
If you would like additional information, more details, or have specific questions about creos syntoprotect mesh, click the link.
References
See Instructions For Use for full prescribing information, including indications, contraindications, warnings and precautions.
- Urban IA, Saleh MHA, Ravidà A, Forster A, Wang HL, Barath Z. Vertical bone augmentation utilizing a titanium-reinforced PTFE mesh: A multi-variate analysis of influencing factors. Clin Oral Implants Res. 2021;32(7):828-839. doi:10.1111/clr.13755
Read on PubMed - Vertical Ridge Augmentation Using Reinforced PTFE Meshes Versus Customized Titanium Meshes. Preliminary Results Of A Randomized Clinical Trial. Sofia Bettini, Carlo Rengo, Antonio Fiorino, Alessandro Cucchi. Presented at the The Italian Academy of Osseointegration (IAO) 2020, Milano, Italy